Gene · 3206
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation and Role of Transcription Factors in Osteogenesis. | Int J Mol Sci | 2021 | 34064134 | PubTator, text mining | PubMed |
| Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome. | Reprod Biol Endocrinol | 2021 | 34053455 | PubTator, text mining | PubMed |
| The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML. | J Transl Med | 2021 | 34051812 | PubTator, text mining | PubMed |
| Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis. | Cell Death Dis | 2021 | 34050127 | PubTator, text mining | PubMed |
| Integrative molecular characterization of pediatric spinal ependymoma: the UK Children's Cancer and Leukaemia Group study. | Neurooncol Adv | 2021 | 34041479 | PubTator, text mining | PubMed |
| The role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium. | Clin Epigenetics | 2021 | 34034824 | PubTator, text mining | PubMed |
| Decreased PIBF1/IL6/p-STAT3 during the mid-secretory phase inhibits human endometrial stromal cell proliferation and decidualization. | J Adv Res | 2021 | 34026283 | PubTator, text mining | PubMed |
| lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis. | Braz J Med Biol Res | 2021 | 34008749 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases: promising targets for cancer therapy. | Exp Mol Med | 2021 | 34006904 | PubTator, text mining | PubMed |
| The language of chromatin modification in human cancers. | Nat Rev Cancer | 2021 | 34002060 | PubTator, text mining | PubMed |
| Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. | Leukemia | 2021 | 34002029 | PubTator, text mining | PubMed |
| The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. | Theranostics | 2021 | 33995677 | PubTator, text mining | PubMed |
| hsa_circ_001946 elevates HOXA10 expression and promotes the development of endometrial receptivity via sponging miR-135b. | Diagn Pathol | 2021 | 33993878 | PubTator, text mining | PubMed |
| LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer. | J Ovarian Res | 2021 | 33992120 | PubTator, text mining | PubMed |
| Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity. | Nat Commun | 2021 | 33990599 | PubTator, text mining | PubMed |
| Transcriptional analysis of muscle tissue and isolated satellite cells in spastic cerebral palsy. | Dev Med Child Neurol | 2021 | 33987836 | PubTator, text mining | PubMed |
Binding of microRNA-135a (miR-135a) to homeobox protein A10 (HOXA10) mRNA in a high-progesterone environment modulates the embryonic implantation factors beta3-integrin (ITGβ3) and empty spiracles homeobox-2 (EMX2). | Ann Transl Med | 2021 | 33987360 | PubTator, text mining | PubMed |
| Acute Myelogenous Leukemia with the t(7;7)(p15;p22) Translocation, a Novel Simple Variant of t(7;11)(p15;p15) Translocation: First Description. | Case Rep Hematol | 2021 | 33986963 | PubTator, text mining | PubMed |
| MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin. | Cancer Manag Res | 2021 | 33981163 | PubTator, text mining | PubMed |
| Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML. | Mol Cell | 2021 | 33974912 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3206/papers?page=48